BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 201043)

  • 1. [Effectiveness of the use of diphenin in insuloma].
    Agapova EN; Mikhalev ID
    Ter Arkh; 1977; 49(9):124-5. PubMed ID: 201043
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inappropriate secretion of insulin by an islet cell adenoma. Trial treatment with diphenylhydantoin].
    Bricaire H; Luton JP; Wechsler B; Messing B; Halaby G
    Ann Med Interne (Paris); 1976 May; 127(5):403-7. PubMed ID: 189663
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conservative treatment of pancreatic insulin-secreting insulinoma].
    Muszyński J
    Pol Arch Med Wewn; 1978 Mar; 59(3):361-6. PubMed ID: 209417
    [No Abstract]   [Full Text] [Related]  

  • 4. [Streptozotocin therapy for metastasizing insuloma].
    Seyer-Hansen K
    Ugeskr Laeger; 1974 Jan; 136(3):153-5. PubMed ID: 4362658
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter: Phenytoin in metastatic insulinoma.
    Aderka D; Shaklai M; Doron M; Laron Z; Pinkhas J; De Vries A
    JAMA; 1975 Dec; 234(11):1119. PubMed ID: 171459
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of diphenylhydantoin upon glucose-induced insulin secretion in three patients with insulinoma.
    Hofeldt FD; Dippe SE; Levin SR; Karam JH; Blum MR; Forsham PH
    Diabetes; 1974 Mar; 23(3):192-8. PubMed ID: 4361409
    [No Abstract]   [Full Text] [Related]  

  • 7. [Is the medical treatment of insulinomas justified? Experience with 9 cases].
    Abascal J; Farndon JR; Johnston ID
    Rev Esp Enferm Apar Dig; 1978 Oct; 54(4):335-50. PubMed ID: 217048
    [No Abstract]   [Full Text] [Related]  

  • 8. [Malignant insuloma. Evaluation of the response to treatment with streptozotocin, using selective arteriography of the celiac axis].
    Neri G; Caresano A; Croce F
    Minerva Med; 1978 Jun; 69(29):1983-90. PubMed ID: 210429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of doxorubicin therapy for advanced islet cell carcinoma.
    Moertel CG; Lavin PT; Hahn RG
    Cancer Treat Rep; 1982 Jul; 66(7):1567-9. PubMed ID: 6284361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of malignant insuloma response to streptozotocin therapy by celiac angiography.
    Neri G; Caresano A; Croce F
    Panminerva Med; 1977; 19(1):45-52. PubMed ID: 189272
    [No Abstract]   [Full Text] [Related]  

  • 11. [Artificial pancreas in the treatment of insulinomas].
    Mercati U; Gerli P; Calabrese G; Santeusanio F
    Minerva Chir; 1989 Jan; 44(1-2):173-6. PubMed ID: 2540455
    [No Abstract]   [Full Text] [Related]  

  • 12. [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].
    Ligorria C; Montaña E; Virgili N
    Med Clin (Barc); 1989 Nov; 93(17):676. PubMed ID: 2559266
    [No Abstract]   [Full Text] [Related]  

  • 13. [Localization of beta-Langerhans tumors secreting hypoglycemics].
    Turner RC; Dick R; Lee EC
    Journ Annu Diabetol Hotel Dieu; 1983; ():131-8. PubMed ID: 6139498
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin analogues in the management of benign insulinomas.
    Laron Z
    Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vipomas and treatment with streptozotocin: 2 cases].
    Lacroute JM; Sondag D; Baumann R; Abbas A; Schutz JF; Wolff JL; Weill-Bousson M; Weill JP
    Gastroenterol Clin Biol; 1983 Jan; 7(1):14-22. PubMed ID: 6301919
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy of metastatic islet cell carcinoma. Report of 4 cases and review of the literature.
    Vasen HF; Sitsen JM; Nortier JW; Lips CJ
    Neth J Med; 1985; 28(4):172-5. PubMed ID: 2987713
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of metastasizing islet cell tumor with streptozotocin].
    Nieschlag E; Wombacher H; Kroeger FJ; Habighorst LV
    Acta Endocrinol (Copenh); 1971 Jun; 67(2):405-16. PubMed ID: 4325333
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcium antagonist (diltiazem) for reversal of hypoglycaemic symptoms in insulinoma.
    Taniguchi H; Murakami K; Morita S; Kazumi T; Yoshino G; Maeda M; Baba S
    Lancet; 1977 Sep; 2(8036):501. PubMed ID: 70702
    [No Abstract]   [Full Text] [Related]  

  • 19. Response of glucagonoma syndrome to lomustine.
    Khandekar JD; Sriratana P
    Cancer Treat Rep; 1986 Mar; 70(3):433-4. PubMed ID: 3006914
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of artificial beta cell in diagnosis and treatment of insulinoma.
    Raptis S; Zoupas C; Dimitriadis G; Moulopoulos S
    Horm Metab Res Suppl; 1979; (8):169-72. PubMed ID: 231567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.